The Management of Lagos State University Teaching Hospital (LASUTH) has intensified its efforts to continually sensitise its staff and the general public on COVID-19 and related issues as it hosted the 3rd edition of its monthly webinar which is aimed at mitigating the effects of the dreaded disease in the society.
Welcoming the participants and guest speakers, the Chief Medical Director, LASUTH, Prof. Adetokunbo O. Fabamwo said that LASUTH as a tertiary health facility in the epic centre during this pandemic believes that it has the responsibility of information dissemination through series like this; “we believe that with our core of expertise, we are in a highly placed position to seek for speakers to share information on the variety of issues concerning the COVID-19 experience.”
In the opening lecture, the Chief Executive Officer of Lagoon Hospital, Dr. Olujimi Coker x-rayed the topic: “Telemedicine in the Post COVID Era”.
He gave insight into how telemedicine has assisted in the treatment of patients during this pandemic and how effective it is. He, however, gave the hurdles to achieving telehealth as poor network, data privacy/confidentiality and many other impediments giving ethical consideration and documentation.
He implored the audience to note that the back-end of telehealth management is as important as the front-end in order to create a seamless provision of care.
Dr Coker concluded his session by urging the government to adopt telemedicine after the pandemic as it will enhance healthcare and cushion the effect of the shortage of doctors.
Speaking during the second session, on the “Management of COVID 19: Insights from a UK Hospital”, a Consultant, Respiratory Physician, Northampton General Hospital, England, Dr. Imo Umoh explained the service design, patient flow, staffing and training, treatment pathways, follow-up and rehabilitation, using his hospital as case study.
He emphasized that all units in the hospital must work together as a team in order to defeat the deadly virus. He finished his session by saying that team-work gave the medical profession a better understanding of how to handle the virus.
In the concluding presentation, Prof Frank Chinegwundoh MBE, a Consultant Urologist, Barts Health NHS Trust, London revealed that there is no association between COVID-19 and erectile dysfunction as he extensively spoke on the topic “COVID Era & Erectile Dysfunction; Any Association?”
He further explained that erectile dysfunction has many causes ranging from stress, depression, excess alcohol, tobacco and other factors; he maintained that COVID-19 is not transmitted through sexual intercourse.
The webinar ended with an appreciation from the Director of Clinical Services and Training, Dr Ibrahim Mustafa to the guest speakers and the audience for attending and participating actively.
HEADLINES YOU MIGHT HAVE MISSED FROM BRAND SPUR
CredoLab raises USD 7m to expand its market reach in Africa and other new markets
CredoLab, a leading developer of bank-grade digital credit scorecards based on smartphone metadata which launched in Nigeria, Kenya, and South Africa, last year, has secured USD 7 million in its Series-A round funding led by GBG, the global specialist in identity data intelligence.
Cars with embedded connectivity to reach 200m by 2025, with 5G adoption set to soar
A new study from Juniper Research has found that the number of cars with embedded connectivity will reach 200 million globally by 2025; rising from 110 million in 2020. One of the main beneficiaries of this growth will be mobile
Nitro121 promises bespoke offerings to clients, celebrates 15th anniversary
The leading brand-building and marketing communication company, Nitro 121 (formerly known as 141 Worldwide), turns fifteen on the 1st of September 2020 and promises to continue to deliver bespoke marketing communications services to clients and other partners.
Top 25 most valuable aerospace and defence brands could lose over $22bn of brand value from COVID-19
Aerospace and defence sector heavily impacted by COVID-19 pandemic, brands could lose up to 20% of brand value, equating to a US$22.8 billion loss cumulatively
